CLINICAL_TRIALS
trial_result
· 2024-03-08
Clinical Trial Update: Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046) [Phase 1]
Summary
Phase 1 trial update of bintrafusp alfa in combination therapy for cervical cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Cervical Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-03-08